A phase III randomised study comparing two differentdose-intensity regimens as induction chemotherapy followedby thoracic irradiation in patients with advanced locoregionalnon-small-cell lung cancer
Jean‐Paul Sculier, Jean‐Jacques Lafitte, Thierry Berghmans et al. · Annals of Oncology · 2004
Cited by 23 works. doi:10.1093/annonc/mdh105 Open-access PDF
Authors
- Jean‐Paul Sculier
- Jean‐Jacques Lafitte
- Thierry Berghmans
- P. Van Houtte
- J. Lecomte
- Jacques Thiriaux
- Anna P. Efremidis
- George Koumakis
- Michel Richez
- J L Corhay
- Patricia Wackenier
- Philippe Lothaire
- Marianne Paesmans
- P. Mommen
- Vincent Ninane
References
- Revisions in the International System for Staging Lung Cancer
- A New International Staging System for Lung Cancer
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
- On the Use of Pocock and Simon's Method for Balancing Treatment Numbers over Prognostic Factors in the Controlled Clinical Trial
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients